Skip to content
Lower risk Drug recall · FDA · Published December 11, 2023

Legacy Pharmaceutical Sertraline Tablets Recall: Risk of Product Contamination

Legacy Pharmaceutical Packaging LLC recalls Sertraline 100mg tablets (NDC 68645-523-54) due to potential product contamination from inadequate line clearance during manufacturing. Affected lots may have mixed products.

🇺🇸 FDA recall #D-0205-2024DrugLegacy Pharmaceutical Packaging LLC ›
Take action

Contact the company

Recalling firmLegacy Pharmaceutical Packaging LLC13333 Lakefront Dr · Earth City, MO 63045-1514
✎ GovInfoNow plain-language explainer

What happened, in plain English

Legacy Pharmaceutical Packaging LLC is recalling Sertraline 100mg tablets that could have been contaminated during manufacturing. This recall affects people who took these specific tablets and may require checking their medication labels. Read more at govinfonow.com/recall/32929-legacy-pharmaceutical-sertraline-tablets-recall-risk-of-product-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/32929-legacy-pharmaceutical-sertraline-tablets-recall-risk-of-product-contamination · Updated August 17, 2026 · FDA enforcement record: FDA #D-0205-2024

Cite this page

“Legacy Pharmaceutical Sertraline Tablets Recall: Risk of Product Contamination.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32929-legacy-pharmaceutical-sertraline-tablets-recall-risk-of-product-contamination. Based on FDA recall #D-0205-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0205-2024%22&limit=1).

Why it’s dangerous

Inadequate line clearance during manufacturing could cause product contamination. This means some tablets might have mixed with other products, potentially affecting safety.

Who’s affected

People who purchased Sertraline 100mg tablets with the NDC code 68645-523-54 from Wal-Mart stores in Bentonville, AR. Those with mental health conditions requiring this medication are most at risk.

How to tell if you have this one

Check for the NDC code 68645-523-54 on the bottle label. The lot number is 222033 with an expiration date of August 31, 2024.

  • Brand
    Legacy Pharmaceutical Packaging LLC
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Label

    Look for the NDC code 68645-523-54 and lot number 222033 on the bottle.

Where it went and when

Where it was distributed

Distributed in Arkansas and California.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: yesARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “CA and AR” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Arkansas, California.

Recall timeline

FDA published this recall 23 days after the firm started it.

1. Firm started the recall: Dec 11, 202312. FDA classified it Class II: Dec 26, 202323. Published in FDA’s Enforcement Report: Jan 3, 2024320232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this recall dangerous?

The recall is for potential product contamination due to manufacturing issues, but no injuries have been reported.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0205-2024 (December 11, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0205-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA